There’s Still Time to Buy Walgreens Boots Alliance Inc (NASDAQ:WBA) Stock

In yesterday’s Wall Street session, Walgreens Boots Alliance Inc (NASDAQ:WBA) shares traded at $17.73, down -1.61% from the previous session.

WBA stock price is now -11.06% away from the 50-day moving average and -22.66% away from the 200-day moving average. The market capitalization of the company currently stands at $15.30B.

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

Sponsored

With the price target of $23, Leerink Partners recently initiated with Market Perform rating for Walgreens Boots Alliance Inc (NASDAQ: WBA). , while ‘Barclays’ rates the stock as ‘Underweight’

In other news, Bhandari Inderpal S, Director bought 3,000 shares of the company’s stock on Apr 11 ’24. The stock was bought for $54,150 at an average price of $18.05. Upon completion of the transaction, the Director now directly owns 3,000 shares in the company, valued at $53190.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Apr 02 ’24, EVP and Global CFO Mahajan Manmohan bought 6,000 shares of the business’s stock. A total of $116,280 was incurred on buying the stock at an average price of $19.38. This leaves the insider owning 166,969 shares of the company worth $2.96 million. A total of 17.52% of the company’s stock is owned by insiders.

During the past 12 months, Walgreens Boots Alliance Inc has had a low of $17.49 and a high of $35.36. As of last week, the company has a debt-to-equity ratio of 2.57, a current ratio of 0.66, and a quick ratio of 0.32.

According to the Pharmaceutical Retailers Company, earnings per share came in at 1, missing analysts’ expectations of 1.07 by -0.07. This compares to $0.63 EPS in the same period last year. The net profit margin was -4.18% and return on equity was -34.82% for WBA. The company reported revenue of $37.05 billion for the quarter, compared to $34.86 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 6.28 percent. For the current quarter, analysts expect WBA to generate $36.01B in revenue.

Related Posts